ROIV
Roivant Sciences Ltd
39.80$
-0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 85.4% | 89.6% | 81.3% | 83.0% | 75.3% | 93.2% | 92.0% | 90.2% | |
| 61.2% | 88.2% | 79.3% | 79.7% | 70.2% | 90.5% | 49.9% | 24.8% | |
| 61.2% | 88.2% | 79.3% | 79.7% | 70.4% | 90.6% | 89.9% | 75.0% | |
| 0.8% | 0.6% | 0.5% | 0.3% | 1.6% | 1.1% | – | 13.8% | |
| – | 0.0% | 2.4% | -0.6% | 0.1% | 0.5% | – | – | |
| 0.8% | 3.0% | 2.9% | 1.0% | 1.6% | – | – | – | |
| – | – | – | – | 6.1% | 1.9% | – | – | |
| 32.5% | 14.9% | 19.6% | 20.3% | 32.7% | 10.7% | 4.6% | 7.6% | |
| 15.2% | 3.7% | 8.1% | 7.1% | 11.4% | 3.7% | 2.7% | 4.9% | |
| 1.5% | 0.3% | 0.5% | 0.4% | 2.2% | 0.3% | 0.2% | 0.2% | |
| 0.4% | 0.4% | 0.8% | 1.3% | 1.6% | 0.7% | 0.4% | 0.3% | |
| – | – | 6.3% | 8.1% | 15.7% | 6.0% | – | – | |
| 67.5% | 82.0% | 70.6% | 64.1% | 48.5% | 82.6% | 86.2% | 79.0% | |
| -166.4% | -44.8% | -71.3% | -106.9% | -157.9% | 8.0% | 2.1% | -8.8% | |
| 15.5% | 27.6% | 25.5% | 25.9% | 29.8% | 11.5% | 13.3% | 12.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.